Literature DB >> 11420081

Lateral parabrachial lesions impair taste aversion learning induced by blood-borne visceral stimuli.

I Cubero1, M Lopez, M Navarro, A Puerto.   

Abstract

The lateral parabrachial area (LPB), main relay from the area postrema (AP), plays a role in processing visceral information and is thus of potential importance in taste aversion learning (TAL). This study used a lesion approach to address whether LPB functional relevance depends upon the features of toxins that serves as visceral stimuli in TAL. In addition, we explored whether LPB involvement in TAL is restricted to those toxic events detected by the AP or whether it has a more general role. Results showed that LPB-lesioned animals were disrupted in acquiring a TAL induced by blood-borne AP-dependent aversive stimuli (intraperitoneal methylscopolamine) and by AP-independent stimulus (intraperitoneal ethanol), but still, clearly developed strong aversions when intragastric hypertonic sodium chloride, a vagally processed aversive stimulus, served as the aversive stimulus. These findings suggest that the LPB plays a critical role in TAL induced by blood-borne toxins, such as methylscopolamine or ethanol, but is not necessary for vagally mediated stimulus, such as sodium chloride. The present results are discussed in the context of the hypothesis holding separable and independent neural systems underlying TAL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420081     DOI: 10.1016/s0091-3057(01)00494-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Central gustatory lesions and learned taste aversions: unconditioned stimuli.

Authors:  Suriyaphun S Mungarndee; Robert F Lundy; Ralph Norgren
Journal:  Physiol Behav       Date:  2006-02-03

2.  Establishing aversive, but not safe, taste memories requires lateralized pontine-cortical connections.

Authors:  Emily Wilkins Clark; Ilene L Bernstein
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.